US Stock MarketDetailed Quotes

BLPH Bellerophon Therapeutics

Watchlist
  • 0.057
  • 0.0000.00%
Close Mar 28 16:00 ET
695.00KMarket Cap-63P/E (TTM)

Bellerophon Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
-61.28%4.38M
-35.23%10.58M
-24.14%15.17M
-72.01%6.92M
-72.01%6.92M
-60.59%11.32M
-52.40%16.33M
-49.59%20M
-47.99%24.74M
-47.99%24.74M
-Cash and cash equivalents
-61.28%4.38M
-35.23%10.58M
-24.14%15.17M
-72.01%6.92M
-72.01%6.92M
-60.59%11.32M
-52.40%16.33M
-49.59%20M
-47.99%24.74M
-47.99%24.74M
Restricted cash
-73.27%108K
-73.45%107K
293.20%405K
293.20%405K
293.20%405K
292.23%404K
291.26%403K
0.00%103K
0.00%103K
0.00%103K
Other current assets
44.67%489K
119.07%563K
-53.03%194K
-62.26%234K
-62.26%234K
-62.36%338K
-71.12%257K
-7.40%413K
47.62%620K
47.62%620K
Total current assets
-58.71%4.98M
-33.81%11.25M
-23.13%15.77M
-70.29%7.56M
-70.29%7.56M
-59.42%12.06M
-51.87%16.99M
-48.99%20.52M
-47.05%25.46M
-47.05%25.46M
Non current assets
Net PPE
--0
--0
-98.79%9K
-80.00%186K
-80.00%186K
-67.41%363K
-57.23%556K
-50.03%743K
-44.41%930K
-44.41%930K
-Gross PPE
--0
--0
-98.79%9K
-20.02%2.71M
-20.02%2.71M
-67.41%363K
-57.23%556K
-50.03%743K
-15.90%3.39M
-15.90%3.39M
-Accumulated depreciation
----
----
----
-2.64%-2.53M
-2.64%-2.53M
----
----
----
-4.32%-2.46M
-4.32%-2.46M
Other non current assets
----
----
-61.73%186K
-61.73%186K
-61.73%186K
-61.73%186K
-61.73%186K
0.00%486K
0.00%486K
0.00%486K
Total non current assets
--0
--0
-84.13%195K
-73.73%372K
-73.73%372K
-65.69%549K
-58.45%742K
-37.71%1.23M
-34.41%1.42M
-34.41%1.42M
Total assets
-60.51%4.98M
-36.58%11.25M
-26.58%15.97M
-70.47%7.94M
-70.47%7.94M
-59.74%12.61M
-52.18%17.73M
-48.46%21.75M
-46.51%26.88M
-46.51%26.88M
Liabilities
Current liabilities
Payables
-59.87%612K
-5.98%1.89M
-51.21%1.07M
3.19%1.23M
3.19%1.23M
19.33%1.53M
-19.20%2.01M
-42.41%2.19M
-68.00%1.19M
-68.00%1.19M
-accounts payable
-59.87%612K
-5.98%1.89M
-51.21%1.07M
3.19%1.23M
3.19%1.23M
19.33%1.53M
-19.20%2.01M
-42.41%2.19M
-68.00%1.19M
-68.00%1.19M
Current accrued expenses
-80.23%644K
30.78%3.74M
64.34%4.29M
27.67%3.97M
27.67%3.97M
4.79%3.26M
-5.31%2.86M
-26.80%2.61M
-48.23%3.11M
-48.23%3.11M
Current debt and capital lease obligation
----
----
-98.95%8K
-73.01%203K
-73.01%203K
-46.49%396K
-19.51%586K
6.84%765K
6.82%752K
6.82%752K
-Current capital lease obligation
--0
--0
-98.95%8K
-73.01%203K
-73.01%203K
-46.49%396K
-19.51%586K
6.84%765K
6.82%752K
6.82%752K
Current liabilities
-75.75%1.26M
3.17%5.62M
-3.63%5.36M
6.91%5.4M
6.91%5.4M
1.01%5.18M
-12.51%5.45M
-31.17%5.57M
-51.58%5.05M
-51.58%5.05M
Non current liabilities
Long term debt and capital lease obligation
----
----
----
--0
--0
--0
--0
-98.97%8K
-78.77%203K
-78.77%203K
-Long term capital lease obligation
----
----
----
--0
--0
--0
--0
-98.97%8K
-78.77%203K
-78.77%203K
Derivative product liabilities
----
----
----
--0
--0
0.00%1K
-99.40%1K
-99.51%1K
-99.83%1K
-99.83%1K
Total non current liabilities
--0
--0
--0
--0
--0
-99.75%1K
-99.87%1K
-99.08%9K
-86.90%204K
-86.90%204K
Total liabilities
-75.75%1.26M
3.16%5.62M
-3.78%5.36M
2.76%5.4M
2.76%5.4M
-6.23%5.18M
-21.94%5.45M
-38.49%5.58M
-56.16%5.26M
-56.16%5.26M
Shareholders'equity
Share capital
28.42%122K
28.42%122K
9.47%104K
1.05%96K
1.05%96K
0.00%95K
0.00%95K
0.00%95K
0.00%95K
0.00%95K
-common stock
28.42%122K
28.42%122K
9.47%104K
1.05%96K
1.05%96K
0.00%95K
0.00%95K
0.00%95K
0.00%95K
0.00%95K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-3.75%-256.32M
-5.12%-254.39M
-4.78%-249.26M
-8.54%-252.08M
-8.54%-252.08M
-8.37%-247.06M
-8.35%-241.99M
-8.15%-237.89M
-8.28%-232.25M
-8.28%-232.25M
Paid-in capital
2.17%259.92M
2.25%259.9M
2.28%259.75M
0.29%254.52M
0.29%254.52M
0.29%254.4M
0.33%254.18M
0.39%253.96M
0.45%253.77M
0.45%253.77M
Total stockholders'equity
-49.88%3.72M
-54.21%5.62M
-34.43%10.6M
-88.28%2.53M
-88.28%2.53M
-71.20%7.43M
-59.20%12.28M
-51.19%16.17M
-43.48%21.62M
-43.48%21.62M
Total equity
-49.88%3.72M
-54.21%5.62M
-34.43%10.6M
-88.28%2.53M
-88.28%2.53M
-71.20%7.43M
-59.20%12.28M
-51.19%16.17M
-43.48%21.62M
-43.48%21.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments -61.28%4.38M-35.23%10.58M-24.14%15.17M-72.01%6.92M-72.01%6.92M-60.59%11.32M-52.40%16.33M-49.59%20M-47.99%24.74M-47.99%24.74M
-Cash and cash equivalents -61.28%4.38M-35.23%10.58M-24.14%15.17M-72.01%6.92M-72.01%6.92M-60.59%11.32M-52.40%16.33M-49.59%20M-47.99%24.74M-47.99%24.74M
Restricted cash -73.27%108K-73.45%107K293.20%405K293.20%405K293.20%405K292.23%404K291.26%403K0.00%103K0.00%103K0.00%103K
Other current assets 44.67%489K119.07%563K-53.03%194K-62.26%234K-62.26%234K-62.36%338K-71.12%257K-7.40%413K47.62%620K47.62%620K
Total current assets -58.71%4.98M-33.81%11.25M-23.13%15.77M-70.29%7.56M-70.29%7.56M-59.42%12.06M-51.87%16.99M-48.99%20.52M-47.05%25.46M-47.05%25.46M
Non current assets
Net PPE --0--0-98.79%9K-80.00%186K-80.00%186K-67.41%363K-57.23%556K-50.03%743K-44.41%930K-44.41%930K
-Gross PPE --0--0-98.79%9K-20.02%2.71M-20.02%2.71M-67.41%363K-57.23%556K-50.03%743K-15.90%3.39M-15.90%3.39M
-Accumulated depreciation -------------2.64%-2.53M-2.64%-2.53M-------------4.32%-2.46M-4.32%-2.46M
Other non current assets ---------61.73%186K-61.73%186K-61.73%186K-61.73%186K-61.73%186K0.00%486K0.00%486K0.00%486K
Total non current assets --0--0-84.13%195K-73.73%372K-73.73%372K-65.69%549K-58.45%742K-37.71%1.23M-34.41%1.42M-34.41%1.42M
Total assets -60.51%4.98M-36.58%11.25M-26.58%15.97M-70.47%7.94M-70.47%7.94M-59.74%12.61M-52.18%17.73M-48.46%21.75M-46.51%26.88M-46.51%26.88M
Liabilities
Current liabilities
Payables -59.87%612K-5.98%1.89M-51.21%1.07M3.19%1.23M3.19%1.23M19.33%1.53M-19.20%2.01M-42.41%2.19M-68.00%1.19M-68.00%1.19M
-accounts payable -59.87%612K-5.98%1.89M-51.21%1.07M3.19%1.23M3.19%1.23M19.33%1.53M-19.20%2.01M-42.41%2.19M-68.00%1.19M-68.00%1.19M
Current accrued expenses -80.23%644K30.78%3.74M64.34%4.29M27.67%3.97M27.67%3.97M4.79%3.26M-5.31%2.86M-26.80%2.61M-48.23%3.11M-48.23%3.11M
Current debt and capital lease obligation ---------98.95%8K-73.01%203K-73.01%203K-46.49%396K-19.51%586K6.84%765K6.82%752K6.82%752K
-Current capital lease obligation --0--0-98.95%8K-73.01%203K-73.01%203K-46.49%396K-19.51%586K6.84%765K6.82%752K6.82%752K
Current liabilities -75.75%1.26M3.17%5.62M-3.63%5.36M6.91%5.4M6.91%5.4M1.01%5.18M-12.51%5.45M-31.17%5.57M-51.58%5.05M-51.58%5.05M
Non current liabilities
Long term debt and capital lease obligation --------------0--0--0--0-98.97%8K-78.77%203K-78.77%203K
-Long term capital lease obligation --------------0--0--0--0-98.97%8K-78.77%203K-78.77%203K
Derivative product liabilities --------------0--00.00%1K-99.40%1K-99.51%1K-99.83%1K-99.83%1K
Total non current liabilities --0--0--0--0--0-99.75%1K-99.87%1K-99.08%9K-86.90%204K-86.90%204K
Total liabilities -75.75%1.26M3.16%5.62M-3.78%5.36M2.76%5.4M2.76%5.4M-6.23%5.18M-21.94%5.45M-38.49%5.58M-56.16%5.26M-56.16%5.26M
Shareholders'equity
Share capital 28.42%122K28.42%122K9.47%104K1.05%96K1.05%96K0.00%95K0.00%95K0.00%95K0.00%95K0.00%95K
-common stock 28.42%122K28.42%122K9.47%104K1.05%96K1.05%96K0.00%95K0.00%95K0.00%95K0.00%95K0.00%95K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -3.75%-256.32M-5.12%-254.39M-4.78%-249.26M-8.54%-252.08M-8.54%-252.08M-8.37%-247.06M-8.35%-241.99M-8.15%-237.89M-8.28%-232.25M-8.28%-232.25M
Paid-in capital 2.17%259.92M2.25%259.9M2.28%259.75M0.29%254.52M0.29%254.52M0.29%254.4M0.33%254.18M0.39%253.96M0.45%253.77M0.45%253.77M
Total stockholders'equity -49.88%3.72M-54.21%5.62M-34.43%10.6M-88.28%2.53M-88.28%2.53M-71.20%7.43M-59.20%12.28M-51.19%16.17M-43.48%21.62M-43.48%21.62M
Total equity -49.88%3.72M-54.21%5.62M-34.43%10.6M-88.28%2.53M-88.28%2.53M-71.20%7.43M-59.20%12.28M-51.19%16.17M-43.48%21.62M-43.48%21.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg